{"id":7235,"date":"2017-08-30T17:54:07","date_gmt":"2017-08-30T21:54:07","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/partner-shayna-sacks-appointed-leadership-role-proton-pump-inhibitor-litigation\/"},"modified":"2017-08-30T17:54:07","modified_gmt":"2017-08-30T21:54:07","slug":"partner-shayna-sacks-appointed-leadership-role-proton-pump-inhibitor-litigation","status":"publish","type":"post","link":"https:\/\/www.napolilaw.com\/article\/partner-shayna-sacks-appointed-leadership-role-proton-pump-inhibitor-litigation\/","title":{"rendered":"Shayna Sacks Appointed Leadership Role in PPI Litigation"},"content":{"rendered":"<p>Napoli Shkolnik  is proud to announce that Partner <a href=\"\/napoli-attorney\/shayna-sacks\/\">Shayna E. Sacks<\/a> was named to the Plaintiffs\u2019 Steering Committee in the In Re: Proton-Pump Inhibitor Products Liability Litigation (MDL 2789) by United Stated District Judge Claire C. Cecchi of the District of New Jersey.<\/p>\n<p>Ms. Sacks brings her substantial mass tort legal acumen and experience to the diverse group of attorneys that were selected by the Hon. Cecchi. In her role, she will oversee all Currently pending individual personal injury and wrongful death cases; Napoli Shkolnik  alone has over 1,000 cases.<\/p>\n<p><a href=\"\/practice-areas\/pharmaceutical-litigation\/prilosec-nexium-prevacid\/\">Prescription proton pump inhibitors <\/a>(PPI\u2019s) are used for controlling acid production in the stomach, which can cause heartburn and\/or acid reflux. Unfortunately, many patients have experienced life-threatening side effects after taking these medications such as Prilosec, Nexium and\/or Prevacid. Some individuals have to take a prescription every day to control the acid production in their stomach even though there might be other remedies available to reduce acid reflux issues naturally.<\/p>\n<p>The lawsuit alleges that as a result of ingesting defective PPI\u2019s, individuals have suffered and continue to suffer from kidney injuries including, acute interstitial nephritis, cornice kidney disease, renal failure and end stage renal disease. Instead of making them better, individuals are in worse shape on the medication.<\/p>\n<p>As a member of the steering committee, Ms. Sacks will continue to investigate and develop the claims in this case by overseeing the coordination, preparation, and presentation of the necessary legal documentation. A team of pharmaceutical litigation attorneys at Napoli Shkolnik , including Partners <a href=\"\/napoli-attorney\/hunter-shkolnik\/\">Hunter J. Shkolnik<\/a> and <a href=\"\/napoli-attorney\/christopher-r-lopalo\/\">Christopher R. LoPalo<\/a>, and Associate <a href=\"\/napoli-attorney\/brett-s-bustamante\/\">Brett S. Bustamante<\/a> will provide valuable assistance to Ms. Sacks.<\/p>\n<p>\u201cI am proud to be part of such a knowledgeable and talented group of attorneys who are ready to fight for the rights of those affected by this product,\u201d says Ms. Sacks. \u201cWe are all committed to providing superior legal representation and together we will work towards the best resolution for our clients.\u201d<\/p>\n<p>Hunter J. Shkolnik added, \u201cThe individuals affected have suffered long enough and deserve to be heard. We are happy to be their voice in this fight.\u201d<\/p>\n<p>We certainly encourage individuals and\/or their loved ones to contact Napoli Shkolnik if they have experienced severe side effects from taking a proton pump inhibitor medication. The <a href=\"\/contact-us\/\">consultation<\/a> is free and there is no obligation or upfront fees. We will review your legal options with you and we only collect a fee if we win your case.<\/p>\n<p>Image Credits: Bigstock.com Keith Homan, Meijir<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Napoli Shkolnik is proud to announce that Partner Shayna E. Sacks was named to the Plaintiffs\u2019 Steering Committee in the In Re: Proton-Pump Inhibitor Products Liability Litigation (MDL 2789) by&#8230;<\/p>\n","protected":false},"author":3,"featured_media":7236,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[776],"tags":[858,865],"class_list":["post-7235","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-litigation","tag-hunter-shkolnik","tag-shayna-sacks"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/www.napolilaw.com\/wp-json\/wp\/v2\/posts\/7235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.napolilaw.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.napolilaw.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.napolilaw.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.napolilaw.com\/wp-json\/wp\/v2\/comments?post=7235"}],"version-history":[{"count":0,"href":"https:\/\/www.napolilaw.com\/wp-json\/wp\/v2\/posts\/7235\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.napolilaw.com\/wp-json\/wp\/v2\/media\/7236"}],"wp:attachment":[{"href":"https:\/\/www.napolilaw.com\/wp-json\/wp\/v2\/media?parent=7235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.napolilaw.com\/wp-json\/wp\/v2\/categories?post=7235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.napolilaw.com\/wp-json\/wp\/v2\/tags?post=7235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}